A breakdown in cellular protein quality control emerges as one of aging's most destructive processes, yet the upstream triggers of this decline have remained elusive. This mechanistic insight could reshape approaches to preventing age-related neurodegeneration and protein aggregation diseases.
The research demonstrates that SIRT6, a key longevity protein, acts as a critical gatekeeper of protein homeostasis by controlling the cell's protein manufacturing centers. When SIRT6 is absent, nucleoli expand dramatically and ramp up ribosomal RNA production, driving excessive protein synthesis. This creates a dangerous imbalance: while protein production surges, the cellular machinery responsible for proper protein folding fails to scale proportionally. The result is an accumulation of misfolded proteins and toxic aggregates that stress cells beyond their capacity to cope.
Experiments in C. elegans worms lacking the SIRT6 equivalent revealed profound consequences: reduced resistance to heat stress, accelerated mobility decline with age, and when combined with disease-prone proteins, premature death. Remarkably, pharmacologically slowing protein synthesis rescued these defects, confirming the causal relationship.
This finding positions SIRT6 as a master regulator of proteostasis, suggesting that maintaining its function could be crucial for healthy aging. The work also reveals how chromatin regulation at the nucleolar level cascades into system-wide cellular dysfunction. For longevity research, this represents a potential therapeutic target where interventions that support SIRT6 activity or carefully modulate protein synthesis rates might prevent the protein aggregation underlying neurodegenerative diseases. However, the complexity of protein homeostasis networks means clinical applications will require careful calibration to avoid disrupting essential cellular processes.
